Weight Variation During Chemotherapy in Breast Cancer Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01506466 |
Recruitment Status
:
Completed
First Posted
: January 10, 2012
Last Update Posted
: July 24, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Weight variation has been reported as a side effect of chemotherapy treatment in early breast cancer patients. To date, there is growing evidence for an increased risk of relapse and death in these patients who gain or lose weight. However, causes of weight variation during chemotherapy and mechanisms involved in the poor prognosis have been little studied.
Thus, the investigators are conducting a prospective study to characterize weight variation in terms of body composition and to identify the mechanisms involved.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Breast Cancer | Other: blood test/ additional measurement | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 52 participants |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Official Title: | Weight Variation and Mechanisms Involved, During Chemotherapy in Breast Cancer Patients |
Study Start Date : | September 2011 |
Actual Primary Completion Date : | March 2013 |
Actual Study Completion Date : | January 2014 |

Arm | Intervention/treatment |
---|---|
additional examinations/measurements |
Other: blood test/ additional measurement
blood test (hormonal, inflammatory, lipid and growth factors); body composition measurements; energy balance evaluation
|
- Change from baseline in body composition [ Time Frame: within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later. ]
- Change from baseline in energy balance [ Time Frame: within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later. ]resting energy expenditure, physical activity, food records.
- Change from baseline in muscle strength [ Time Frame: within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later. ]
- Change from baseline in biological factors (hormonal, inflammatory, lipid, growth factors) [ Time Frame: within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later. ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 70 Years (Child, Adult, Senior) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- menopausal women
- breast cancer
- patients requiring chemotherapy treatment
- WHO performance status 0-2
Exclusion Criteria:
- diabetics
- patients with metastases
- other cancer

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01506466
France | |
Centre Jean Perrin | |
Clermont-Ferrand, France, 63000 |
Principal Investigator: | Xavier DURANDO, MD, PhD | Centre Jean Perrin |
Responsible Party: | Centre Jean Perrin |
ClinicalTrials.gov Identifier: | NCT01506466 History of Changes |
Other Study ID Numbers: |
2011-A00206-35 |
First Posted: | January 10, 2012 Key Record Dates |
Last Update Posted: | July 24, 2015 |
Last Verified: | July 2015 |
Keywords provided by Centre Jean Perrin:
chemotherapy metabolism weight body composition |
Additional relevant MeSH terms:
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |